News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jaguar announces expansion of out-licensing agreement with Magdalena Biosciences for Botanical Drug Candidate targeting schizophrenia market. Company to present at Lytham Partners Spring 2024 Investor Conference -
-
-
COMMUNIQUÉ DE PRESSE
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency -
-